Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1163 participants
INTERVENTIONAL
2018-09-15
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diabetes Coaching Study
NCT02066831
Tele-Diab: Electronic Diary for Patients With Type 2 Diabetes Mellitus
NCT01058889
Digital, Blended Lifestyle Intervention for Type 2 Diabetes Remission
NCT05346614
The Healthy Eating and Active Living to Reverse Diabetes Pilot Study
NCT07316569
Helping Adults With Type 2 Diabetes Use Their Health Data for Healthy Diabetes Self-Management
NCT06848361
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants of both groups will enter their anthropometric and metabolic data into a database on quarterly basis. In addition, the costs for diabetes-specific treatment, inpatient and outpatient treatment costs and drug costs will be analyzed on the basis of the routine data of the AOK Rhineland / Hamburg.
Patient preference for type 2 diabetes intervention will be recorded using Discrete Choice Experiment (DCE) questionnaires at the beginning of the program and at the end of the intervention. As part of the development and validation of the DCE, focus groups are used to determine the DCE attributes. In addition, focus groups should also be used during the data collection in order to obtain additional information on patient preferences by means of qualitative analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
The control group will be provided a scale, a step counter as well as access to the online portal and will remain in routine care.
Scale
self-monitoring of body weight; with automatic data transfer into the personalized and secured online portal
Step counter
self-monitoring of physical activity; with automatic data transfer into the personalized and secured online portal
Access to the online portal
self-monitoring of health parameters
TeLIPro group
The TeLIPro group will be provided a scale, a step counter, a blood glucose meter with test stripes as well as access to the online portal and will get telemedical coaching.
Scale
self-monitoring of body weight; with automatic data transfer into the personalized and secured online portal
Step counter
self-monitoring of physical activity; with automatic data transfer into the personalized and secured online portal
Blood glucose meter with test stripes
self-monitoring of blood glucose; with automatic data transfer into the personalized and secured online portal
Access to the online portal
self-monitoring of health parameters
Telemedical coaching
regular telephone calls providing information about T2DM, healthy lifestyle, low-carbohydrate diet and physical activity
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Scale
self-monitoring of body weight; with automatic data transfer into the personalized and secured online portal
Step counter
self-monitoring of physical activity; with automatic data transfer into the personalized and secured online portal
Blood glucose meter with test stripes
self-monitoring of blood glucose; with automatic data transfer into the personalized and secured online portal
Access to the online portal
self-monitoring of health parameters
Telemedical coaching
regular telephone calls providing information about T2DM, healthy lifestyle, low-carbohydrate diet and physical activity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* body mass index of et least 27 kg/m2
Exclusion Criteria
* chronic diseases other than type 2 diabetes and hypertension (e.g., cancer, chronic obstructive pulmonary disease, asthma, dementia, chronic gut diseases, psychoses, liver cirrhosis, macronephropathy/nephropathy, kidney insufficiency with glomerular filtration rate \<30 ml/min/1.73 m2)
* acute chemotherapy or chronic cortisol treatment
* smoking cessation for \<3 months and/or planned smoking cessation during study
* pregnancy or breast-feeding
25 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AOK Rheinland/Hamburg
INDUSTRY
German Institute for Telemedicine and Health Promotion
OTHER
German Diabetes Center
OTHER
West German Center of Diabetes and Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephan Martin
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bernd Altpeter
Role: STUDY_CHAIR
Deutsches Institut für Telemedizin und Gesundheitsförderung
Sibel Altin
Role: STUDY_CHAIR
AOK Rheinland/Hamburg
Andrea Icks, PhD
Role: STUDY_CHAIR
Deusches Diabetes Zentrum
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West German Centre of Diabetes and Health
Düsseldorf, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TeLIPro
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.